New Approach to Resistant Depression
For some individuals, traditional antidepressant medications may not provide enough relief. Spravato® (esketamine) is an FDA-approved treatment designed for adults experiencing treatment-resistant depression.
At One Behavioral Missouri, Spravato treatment is provided in a carefully supervised clinical setting. Our providers guide patients through the process with personalized care and ongoing support to help improve symptoms and overall wellbeing.
How Does Spravato Treatment Work?
Spravato treatment works differently from traditional antidepressants. It targets brain pathways involved in mood regulation and can help improve symptoms for individuals who have not responded to other medications.
Comprehensive Evaluation
Your provider will review your medical history, current symptoms, and previous treatments to determine if Spravato is appropriate for your care.
In-Office Treatment Sessions
Spravato is administered in our clinic under medical supervision. During each session, our team monitors your comfort and response to treatment.
Ongoing Monitoring and Support
After each session, patients remain in the clinic for observation before returning home. Follow-up visits help track progress and adjust treatment when needed.
Conditions Spravato Treatment Can Help With
Spravato treatment may benefit individuals experiencing severe depression that has not improved with other treatments.
Our providers may recommend Spravato for patients experiencing:
- Treatment-resistant depression
- Persistent depressive symptoms
- Depression not improved with multiple medications
- Severe depressive episodes affecting daily life
A full evaluation is required to determine whether this treatment is appropriate for each patient.
When Should You Consider Spravato Treatment?
Spravato may be considered when traditional treatment approaches have not provided sufficient relief.
You may be a candidate for Spravato treatment if:
- You have tried multiple antidepressant medications without improvement
- Your depressive symptoms remain severe or persistent
- Previous treatments have not produced meaningful results
- Your provider recommends exploring advanced treatment options
Our team carefully evaluates each patient to determine whether Spravato treatment is the right option.
Ready to Get Started?
Speak with our team about treatment options.
Our providers can help determine whether Spravato treatment may be appropriate for your needs. We guide patients through every step of the evaluation and treatment process.
New to One Behavioral Missouri?
Beginning treatment should feel clear and supportive.
- Schedule a consultation with a provider
- Complete intake and evaluation forms
- Discuss treatment history and options
- Begin a personalized treatment plan if appropriate
Our team is available to answer questions about scheduling, insurance, and treatment expectations.
Common Questions About Spravato Treatment
Spravato is an FDA-approved medication derived from esketamine that is used to treat adults with treatment-resistant depression.
Spravato works on different pathways in the brain and may help improve symptoms when traditional medications have not been effective.
No. Spravato must be administered in a certified healthcare setting under medical supervision.
Each visit typically includes administration of the medication followed by a monitoring period before patients are cleared to leave the clinic.
Why One Behavioral Missouri?
Thoughtful care for complex depression.
At One Behavioral Missouri, advanced treatments like Spravato are provided in a supportive clinical environment with experienced providers who prioritize patient safety and comfort.
Our goal is to help individuals who have struggled with persistent depression explore new treatment options with compassionate, evidence-based care.
Let's Get Started.
Book an Appointment With Us
If you are experiencing persistent depression that has not improved with traditional treatment, our team can help determine whether Spravato treatment may be an appropriate option.